Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• ID, mental health share complicated relationship
• Five-step plan aims to reduce infection-related deaths in young children
• Candida auris reported in US for first time
• Congressman Tom Price, MD, nominated as HHS secretary
• Contaminated airport door handles may fuel antimicrobial resistance internationally
• English patient received HIV-positive to HIV-positive liver transplant in 2011
• Expanded access to syringe service programs needed to limit HCV, HIV infections
• Florida officials approve investigational use of genetically modified mosquitoes
• ID experts anxious, uncertain about Trump presidency
• Researchers discover late-onset Zika-associated microcephaly
• Nearly 3% of US adult population immunosuppressed
• New phase 3 data demonstrate safety, efficacy of ibalizumab
• Nosocomial respiratory infections in neonates associated with increased morbidity, costs
• OB/GYNs can improve vaccination among women
• Officials say $1.5 billion needed to finish job of polio eradication
• Perinatally HIV linked to cognitive impairment in children
• S. aureus, skin infection correlation identified in industrial hog operation workers
• Sexual health surveys improve STI screening among youth in ED
• Surveys highlight gaps in antibiotic awareness among the public
• WHO: Zika is no longer a global health emergency
• WHO gains funds needed to launch pilot implementation of malaria vaccine
• WHO releases new guidance for HIV self-testing
• WHO releases recommendations for preventing SSIs
• Young suburban drug users drive ‘second wave’ of HCV epidemic
• Zika vaccine may be ready by 2018
• Researchers explore link between infection and Alzheimer’s disease
• A new focus in HIV care: Smoking cessation Abimbola Farinde, PhD
• What has happened to avian influenza in humans? Donald Kaye, MD, MACP
• FDA approves Vemlidy for chronic HBV
• FDA approves Zinplava to reduce C. difficile infection recurrence
• 2014-2015 influenza vaccine ‘ineffective’ against A/H3N2, effective against influenza B
• After decades of decline, ID mortality rate has 'leveled off'
• Antimicrobial stewardship reduces C. difficile prevalence, drug resistance
• Antiviral treatment increases among US patients
• Catheter interventions reduce bloodstream infections, cut infection-related costs
• Chikungunya more prevalent in women
• Childhood influenza exposure subtype predicts future immunity
• Delayed HBV, HCV diagnosis may increase advanced liver disease
• Eravacycline noninferior to ertapenem in patients with cIAIs
• First-line drugs result in suboptimal outcomes for patients with isoniazid-resistant TB
• Only half of HCV patients with advanced liver disease receive treatment
• Harvoni well-tolerated in patients with kidney transplant, HCV
• HCV shed in rectums of HIV-infected MSM
• HEV found among patients with Guillain-Barré syndrome
• High-dose rifampicin shows promise in TB
• IDSA, ASTMH release leishmaniasis guidelines following increase in US cases
• Infection, not antibiotic use, linked to childhood obesity
• Life expectancy for HIV patients approaches that of general population
• 'Minimally symptomatic' cases show Ebola outbreak may have been larger
• Decline in pulmonary TB hospitalizations among children not associated with PCV
• Pneumococcal infections decrease among patients with suppressed HIV
• PrEP regimens containing Selzentry safe, well-tolerated compared with Truvada
• Promoting ASPs through social media reinforces stewardship practices
• Rates of pediatric pneumonia associated with use of solid fuels
• Red squirrels in UK, Ireland carry leprosy
• Researchers develop USB stick that tests for HIV
• Researchers rule out environmental factors in complications from home infusion therapy
• Smoking more harmful than HIV in patients adhering to ART
• Travelers may harbor ESBL-E up to 1 year
• Triggered vaccination campaigns could reduce size, severity of measles outbreaks
• Two-dose regimens of Gardasil 9 noninferior to three-dose regimens
• DAA therapy improves patient-reported outcomes despite cirrhosis, ribavirin use
• Half of patients with resistant infections receive delayed antibiotics
• Implementation policies crucial to improve global vaccination coverage
• MODIFY: Zinplava reduces C. diff recurrence regardless of antibiotic choice
• One in five C. difficile patients re-hospitalized within 30 days
• Project CLEAR: Serial decolonization reduces MRSA infection after hospital discharge
• Researchers define ‘skip phenomenon’ in patients with S. aureus bacteremia
• Researchers say simultaneous infection of Zika, chikungunya possible
• Treated bed nets still effective against malaria, but resistance a concern
• West Nile virus increases risk for mortality years after infection
• Treatment of MDR gram-negative infections: A review of combination regimens Kati Shihadeh, PharmD, BCIDP; Lana T. Al-Omar, PharmD